New approaches to thrombolytic therapy.
暂无分享,去创建一个
[1] D. Collen,et al. In Vitro Fibrinolytic Activity of Recombinant Tissue-Type Plasminogen Activator in the Plasma of Various Primate Species , 1984, Thrombosis and Haemostasis.
[2] M. Colucci,et al. Identification of plasminogen activator releasing activity in the neurohypophysis , 1984, British journal of haematology.
[3] E. Kruithof,et al. Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma. , 1984, Blood.
[4] D. Loskutoff,et al. Detection and partial characterization of an inhibitor of plasminogen activator in human platelets. , 1984, The Journal of clinical investigation.
[5] D. Pennica,et al. Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells. , 1984, The Journal of pharmacology and experimental therapeutics.
[6] J. J. Spadaro,et al. Coronary thrombolysis with recombinant human tissue-type plasminogen activator. , 1984, Circulation.
[7] D. Collen,et al. Biological and Thrombolytic Properties of Proenzyme and Active Forms of Human Urokinase – II. Turnover of Natural and Recombinant Urokinase in Rabbits and Squirrel Monkeys , 1984, Thrombosis and Haemostasis.
[8] M. Blaber,et al. Biological and Thrombolytic Properties of Proenzyme and Active Forms of Human Urokinase – III. Thrombolytic Properties of Natural and Recombinant Urokinase in Rabbits with Experimental Jugular Vein Thrombosis , 1984, Thrombosis and Haemostasis.
[9] D. Collen,et al. Biological and Thrombolytic Properties of Proenzyme and Active Forms of Human Urokinase – IV. Variability in Fibrinolytic Response of Plasma of Several Mammalian Species , 1984, Thrombosis and Haemostasis.
[10] D. Collen,et al. Biological and Thrombolytic Properties of Proenzyme and Active Forms of Human Urokinase – I. Fibrinolytic and Fibrinogenolytic Properties in Human Plasma In Vitro of Urokinases Obtained from Human Urine or by Recombinant DNA Technology , 1984, Thrombosis and Haemostasis.
[11] D. Collen,et al. Influence of exogenous and endogenous tissue-type plasminogen activator on the lysability of clots in a plasma milieu in vitro. , 1984, Thrombosis research.
[12] M. Colucci,et al. Influence of protein C activation on blood coagulation and fibrinolysis in squirrel monkeys. , 1984, The Journal of clinical investigation.
[13] V. Gurewich,et al. Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species. , 1984, The Journal of clinical investigation.
[14] E. Brommer. The level of extrinsic plasminogen activator (t-PA) during clotting as a determinant of the rate of fibrinolysis; inefficiency of activators added afterwards. , 1984, Thrombosis research.
[15] B. Wiman,et al. Inactivation of tissue plasminogen activator in plasma. Demonstration of a complex with a new rapid inhibitor. , 1984, The Journal of biological chemistry.
[16] F. Van de Werf,et al. Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction. , 1984, The New England journal of medicine.
[17] B. Sobel,et al. Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology. , 1984, Circulation.
[18] D. Collen,et al. Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditions. , 1984, Thrombosis research.
[19] L. Patthy,et al. Common evolutionary origin of the fibrin‐binding structures of fibronectin and tissue‐type plasminogen activator , 1983, FEBS letters.
[20] B. Wiman,et al. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. , 1983, Thrombosis research.
[21] J. Staessen,et al. Effect of prostaglandin synthesis inhibition on blood pressure and humoral factors in normal, sodium-deplete man at exercise , 1983 .
[22] T. Blundell,et al. Adaptation of plasminogen activator sequences to known protease structures , 1983, FEBS Letters.
[23] M. Ter-pogossian,et al. Clot-selective coronary thrombolysis with tissue-type plasminogen activator. , 1983, Science.
[24] B. Risberg,et al. Measurement of plasminogen activator activity in tissues using s 2251 d valyl l leucyl n 4 nitrophenyl l lysinamide di hydro chloride , 1983 .
[25] H. Jörnvall,et al. Differential proteolysis and evidence for a residue exchange in tissue plasminogen activator suggest possible association between two types of protein microheterogeneity , 1983, FEBS letters.
[26] H. Jörnvall,et al. Purification and characterization of a melanoma cell plasminogen activator. , 1983, European journal of biochemistry.
[27] D. Collen,et al. Measurement of human tissue-type plasminogen activator by a two-site immunoradiometric assay. , 1983, The Journal of laboratory and clinical medicine.
[28] M. Verstraete,et al. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration. , 1983, The Journal of clinical investigation.
[29] D. Collen,et al. Complexes between tissue-type plasminogen activator and proteinase inhibitors in human plasma, identified with an immunoradiometric assay. , 1983, The Journal of laboratory and clinical medicine.
[30] V. V. van Hinsbergh,et al. Inhibition of tissue-type plasminogen activator by conditioned medium from cultured human and porcine vascular endothelial cells. , 1983, Biochemical and biophysical research communications.
[31] P. Seeburg,et al. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli , 1983, Nature.
[32] A. Billiau,et al. Purification of Human Tissue-Type Plasminogen Activator in Centigram Quantities from Human Melanoma Cell Culture Fluid and Its Conditioning for Use In Vivo , 1982, Thrombosis and Haemostasis.
[33] J. Zeuthen,et al. Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody. , 1982, Biochemistry.
[34] M. Rånby,et al. Purification and identification of two structural variants of porcine tissue plasminogen activator by affinity adsorption on fibrin. , 1982, Biochimica et biophysica acta.
[35] M. Rånby,et al. Isolation of two variants of native one‐chain tissue plasminogen activator , 1982, FEBS letters.
[36] M. Rånby,et al. Enzymatic properties of the one- and two-chain form of tissue plasminogen activator. , 1982, Thrombosis research.
[37] L. Ossowski,et al. A proenzyme form of human urokinase. , 1982, The Journal of biological chemistry.
[38] M. Hoylaerts,et al. Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator. , 1982, The Journal of biological chemistry.
[39] M. Hoylaerts,et al. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. , 1982, The Journal of biological chemistry.
[40] C. Korninger,et al. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis. , 1982, The Journal of clinical investigation.
[41] W. Weimar,et al. SPECIFIC LYSIS OF AN ILIOFEMORAL THROMBUS BY ADMINISTRATION OF EXTRINSIC (TISSUE-TYPE) PLASMINOGEN ACTIVATOR , 1981, The Lancet.
[42] C. Esmon,et al. Generation of fibrinolytic activity by infusion of activated protein C into dogs. , 1981, The Journal of clinical investigation.
[43] C. Korninger,et al. Turnover of Human Extrinsic (Tissue-Type) Plasminogen Activator in Rabbits , 1981, Thrombosis and Haemostasis.
[44] C. Korninger,et al. Studies on the Specific Fibrinolytic Effect of Human Extrinsic (Tissue-Type) Plasminogen Activator in Human Blood and in Various Animal Species in Vitro , 1981, Thrombosis and Haemostasis.
[45] D. Collen,et al. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. , 1981, The Journal of biological chemistry.
[46] O. Matsuo,et al. Comparison of the Relative Fibrinogenolytic, Fibrinolytic and Thrombolytic Properties of Tissue Plasminogen Activator and Urokinase in Vitro , 1981, Thrombosis and Haemostasis.
[47] O. Matsuo,et al. Thrombolysis by human tissue plasminogen activator and urokinase in rabbits with experimental pulmonary embolus , 1981, Nature.
[48] D. Loskutoff,et al. An Inhibitor Of Plasminogen Activator In Rabbit Endothelial Cells , 1981, Thrombosis and Haemostasis.
[49] C. Mattsson,et al. Dissolution Of Thrombi By Tissue Plasminogen Activator, Urokinase And Streptokinase In An Artificial Circulating System , 1981, Thrombosis and Haemostasis.
[50] D. Collen. On the Regulation and Control of Fibrinolysis , 1980, Thrombosis and Haemostasis.
[51] D. Rijken,et al. Relationship between tissue plasminogen activator and the activators in blood and vascular wall. , 1980, Thrombosis research.
[52] D. Rijken,et al. Purification and partial characterization of plasminogen activator from human uterine tissue. , 1979, Biochimica et biophysica acta.
[53] M. Bernik. Increased plasminogen activator (urokinase) in tissue culture after fibrin deposition. , 1973, The Journal of clinical investigation.
[54] T. Astrup,et al. Fibrinogenolysis and Fibrinolysis with Tissue Plasminogen Activator, Urokinase, Streptokinase-Activated Human Globulin, and Plasmin 1 , 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[55] M. Verstraete,et al. Coronary thrombolysis and infarct size reduction after intravenous infusion of recombinant tissue-type plasminogen activator in nonhuman primates. , 1985, The Journal of clinical investigation.
[56] D. Collen,et al. Coronary thrombolysis and infarct sizes reduction following intravenous infusion of recombinant tissue-type plasminogen activator in non-human primates , 1984 .
[57] S. Husain,et al. Purification and partial characterization of a single-chain high-molecular-weight form of urokinase from human urine. , 1983, Archives of biochemistry and biophysics.
[58] D. Collen,et al. Interaction of Plasminogen Activators and Inhibitors with Plasminogen and Fibrin , 1982, Seminars in thrombosis and hemostasis.
[59] D. Rijken,et al. Immunological characterization of plasminogen activator activities in human tissues and body fluids. , 1981, The Journal of laboratory and clinical medicine.
[60] T. Kosugi,et al. Urokinase inactivation rate in the rabbit: effect of circulatory isolation of the liver, spleen and kidneys. , 1978, Haemostasis.